Binding Sites are compared using Shaper.
For more information, please see the following publication:
Desaphy J. et al. Comparison and Druggability Prediction of protein-Ligand Binding sites from pharmacophore-annotated cavity shapes J. Chem. Inf. Model., 2012, 52(8), pp2287-2299
Binding Sites are considered as similar when the similarity value is greater than 0.44
| PDB ID | HET | Uniprot Name | EC Number |
|---|---|---|---|
| 2qoc | ANP | Ephrin type-A receptor 3 | 2.7.10.1 |
| PDB ID | HET | Uniprot Name | EC Number | Binding Site Similarity |
Align |
|---|---|---|---|---|---|
| 2qoc | ANP | Ephrin type-A receptor 3 | 2.7.10.1 | 1.000 | |
| 4gk4 | L90 | Ephrin type-A receptor 3 | 2.7.10.1 | 0.601 | |
| 2qo7 | ANP | Ephrin type-A receptor 3 | 2.7.10.1 | 0.577 | |
| 2qo9 | ANP | Ephrin type-A receptor 3 | 2.7.10.1 | 0.563 | |
| 4g2f | C07 | Ephrin type-A receptor 3 | 2.7.10.1 | 0.560 | |
| 2hen | ADP | Ephrin type-B receptor 2 | 2.7.10.1 | 0.541 | |
| 2qoq | ANP | Ephrin type-A receptor 3 | 2.7.10.1 | 0.536 | |
| 4gk2 | L66 | Ephrin type-A receptor 3 | 2.7.10.1 | 0.512 | |
| 1qpj | STU | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.509 | |
| 4gk3 | L87 | Ephrin type-A receptor 3 | 2.7.10.1 | 0.509 | |
| 2y6o | 1N1 | Ephrin type-A receptor 4 | 2.7.10.1 | 0.496 | |
| 3vs2 | VSB | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.493 | |
| 2xvd | AS6 | Ephrin type-B receptor 4 | 2.7.10.1 | 0.492 | |
| 2c6e | HPM | Aurora kinase A | 2.7.11.1 | 0.488 | |
| 1jpa | ANP | Ephrin type-B receptor 2 | 2.7.10.1 | 0.487 | |
| 3q4z | ANP | Serine/threonine-protein kinase PAK 1 | 2.7.11.1 | 0.486 | |
| 4jia | 1K3 | Tyrosine-protein kinase JAK2 | / | 0.485 | |
| 1ad5 | ANP | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.484 | |
| 1byg | STU | Tyrosine-protein kinase CSK | / | 0.484 | |
| 2xyu | Q9G | Ephrin type-A receptor 4 | 2.7.10.1 | 0.483 | |
| 1mqb | ANP | Ephrin type-A receptor 2 | 2.7.10.1 | 0.477 | |
| 3oom | 507 | Activin receptor type-1 | 2.7.11.30 | 0.477 | |
| 2h8h | H8H | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.475 | |
| 4j95 | ACP | Fibroblast growth factor receptor 2 | / | 0.474 | |
| 3a4o | STU | Tyrosine-protein kinase Lyn | 2.7.10.2 | 0.472 | |
| 4c3p | ACP | Aurora kinase A | 2.7.11.1 | 0.470 | |
| 2vwu | 7X1 | Ephrin type-B receptor 4 | 2.7.10.1 | 0.468 | |
| 2of4 | 979 | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.467 | |
| 1pkg | ADP | Mast/stem cell growth factor receptor Kit | 2.7.10.1 | 0.464 | |
| 4dgg | I76 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.464 | |
| 4dym | IYZ | Activin receptor type-1 | 2.7.11.30 | 0.464 | |
| 2bdj | HET | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.463 | |
| 3cok | ANP | Serine/threonine-protein kinase PLK4 | 2.7.11.21 | 0.463 | |
| 3vjo | ANP | Epidermal growth factor receptor | 2.7.10.1 | 0.463 | |
| 4qny | ANP | Mitogen activated protein kinase, putative | / | 0.463 | |
| 3lmg | ANP | Receptor tyrosine-protein kinase erbB-3 | 2.7.10.1 | 0.462 | |
| 4mxx | DB8 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.462 | |
| 2x9f | X9F | Ephrin type-B receptor 4 | 2.7.10.1 | 0.461 | |
| 3ac1 | KZI | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.460 | |
| 3ad6 | KSC | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.460 | |
| 5cnn | ANP | Epidermal growth factor receptor | 2.7.10.1 | 0.460 | |
| 2xrw | ANP | Mitogen-activated protein kinase 8 | 2.7.11.24 | 0.459 | |
| 3i60 | E86 | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.459 | |
| 3uvq | FS8 | Mitogen-activated protein kinase 14 | / | 0.459 | |
| 4bb4 | 32W | Ephrin type-B receptor 4 | 2.7.10.1 | 0.459 | |
| 4jbo | WPH | Aurora kinase A | 2.7.11.1 | 0.459 | |
| 2itn | ANP | Epidermal growth factor receptor | 2.7.10.1 | 0.458 | |
| 2yit | YIT | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.458 | |
| 2vx0 | 7X7 | Ephrin type-B receptor 4 | 2.7.10.1 | 0.457 | |
| 2ycq | UPX | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.457 | |
| 1i44 | ACP | Insulin receptor | 2.7.10.1 | 0.456 | |
| 2dcn | ADP | 2-keto-3-deoxy-gluconate kinase | / | 0.456 | |
| 3zew | STU | Ephrin type-B receptor 4 | 2.7.10.1 | 0.456 | |
| 4k33 | ACP | Fibroblast growth factor receptor 3 | 2.7.10.1 | 0.456 | |
| 3bu5 | ATP | Insulin receptor | 2.7.10.1 | 0.455 | |
| 4id7 | 1G0 | Activated CDC42 kinase 1 | / | 0.455 | |
| 2itv | ANP | Epidermal growth factor receptor | 2.7.10.1 | 0.454 | |
| 4gmy | 0X5 | Tyrosine-protein kinase JAK2 | / | 0.454 | |
| 4jbp | YPH | Aurora kinase A | 2.7.11.1 | 0.454 | |
| 4xhg | ADP | Uncharacterized protein | / | 0.454 | |
| 1j1c | ADP | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.453 | |
| 4dfn | 0K1 | Tyrosine-protein kinase SYK | 2.7.10.2 | 0.453 | |
| 4qml | ANP | Serine/threonine-protein kinase 24 | 2.7.11.1 | 0.453 | |
| 1qpd | STU | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.452 | |
| 1qmz | ATP | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.451 | |
| 4bgg | 844 | Activin receptor type-1 | 2.7.11.30 | 0.451 | |
| 2of2 | 547 | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.450 | |
| 3kvx | FMY | Mitogen-activated protein kinase 10 | 2.7.11.24 | 0.450 | |
| 3ori | AGS | Serine/threonine protein kinase | / | 0.450 | |
| 4fl1 | ANP | Tyrosine-protein kinase SYK | 2.7.10.2 | 0.450 | |
| 4mxo | DB8 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.450 | |
| 2py3 | ACP | Fibroblast growth factor receptor 2 | / | 0.449 | |
| 3mtf | A3F | Activin receptor type-1 | 2.7.11.30 | 0.449 | |
| 5e92 | ANP | TGF-beta receptor type-2 | 2.7.11.30 | 0.449 | |
| 2zva | 1N1 | Tyrosine-protein kinase Lyn | 2.7.10.2 | 0.448 | |
| 4oa9 | ANP | Protein BRASSINOSTEROID INSENSITIVE 1 | 2.7.10.1 | 0.448 | |
| 3tti | KBI | Mitogen-activated protein kinase 10 | 2.7.11.24 | 0.447 | |
| 3vrz | VRZ | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.447 | |
| 4riy | ADP | Epidermal growth factor receptor | 2.7.10.1 | 0.447 | |
| 3hx4 | ANP | Calmodulin-domain protein kinase 1 | / | 0.446 | |
| 3vs3 | VSE | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.446 | |
| 4mcv | 29K | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.446 | |
| 4o0r | X4Z | Serine/threonine-protein kinase PAK 1 | 2.7.11.1 | 0.446 | |
| 3i4b | Z48 | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.445 | |
| 4fsr | HKC | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.445 | |
| 4fti | H7K | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.445 | |
| 5dnr | ATP | Aurora kinase A | 2.7.11.1 | 0.445 | |
| 2j0l | ANP | Focal adhesion kinase 1 | 2.7.10.2 | 0.444 | |
| 2xbj | XBJ | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.444 | |
| 3c4w | ATP | Rhodopsin kinase | / | 0.444 | |
| 3ump | ATP | ATP-dependent 6-phosphofructokinase isozyme 2 | 2.7.1.11 | 0.444 | |
| 2v7a | 627 | Tyrosine-protein kinase ABL1 | 2.7.10.2 | 0.443 | |
| 3fzp | AGS | Protein-tyrosine kinase 2-beta | 2.7.10.2 | 0.443 | |
| 3i5z | Z48 | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.443 | |
| 3vth | APC | Carbamoyltransferase | / | 0.443 | |
| 2eb3 | ANP | Epidermal growth factor receptor | 2.7.10.1 | 0.442 | |
| 2itu | ITQ | Epidermal growth factor receptor | 2.7.10.1 | 0.442 | |
| 2o0u | C0M | Mitogen-activated protein kinase 10 | 2.7.11.24 | 0.442 | |
| 4fsn | A58 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.442 | |
| 2itq | ITQ | Epidermal growth factor receptor | 2.7.10.1 | 0.441 | |
| 3b2w | 9NH | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.441 | |
| 3uoz | NAP | 2-oxo-Delta(3)-4,5,5-trimethylcyclopentenylacetyl-CoA monooxygenase | 1.14.13.160 | 0.441 | |
| 3vs6 | VSH | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.441 | |
| 4dit | 0KD | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.441 | |
| 4qmx | H8H | Serine/threonine-protein kinase 24 | 2.7.11.1 | 0.441 | |
| 2exc | JNK | Mitogen-activated protein kinase 10 | 2.7.11.24 | 0.440 | |
| 2hk5 | 1BM | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.440 | |
| 2xch | CKG | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.440 | |
| 3vs1 | VSA | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.440 | |
| 4ux9 | ANP | Mitogen-activated protein kinase 8 | 2.7.11.24 | 0.440 | |
| 4yhj | AN2 | G protein-coupled receptor kinase 4 | 2.7.11.16 | 0.440 |